UMMS scientists co-discover first ‘off-switches’ for CRISPR/Cas9 gene editing

UMMS scientists co-discover first ‘off-switches’ for CRISPR/Cas9 gene editing

Researchers at UMass Medical School and the University of Toronto have discovered the first known “off-switches” for CRISPR/Cas9 genome editing, providing much greater control over the edits, according to a new study published in Cell. Erik Sontheimer, PhD, led the research at UMMS.

Read more

Research at a Glance

Faculty


The Research Enterprise 

  • FY 2015 Grant Funding: $249 M
  • FY 2015 NIH Funding: $141 M
  • 1108 externally Sponsored projects
  • 400 Postdoctoral Scholars
  • 440 Graduate Students
  • $33M in licensing revenue in 2014-15

Participate in Clinical Research

Research Centers and Institutes

 


Support Research@UMMS

Take Action Make a Gift Today - UMass Medical School


Events
Publications
Find an Investigator

▴ Back To Top
Section Menu To Top
Office of research CCTS research @ umms